3D Printing and Bioprinting for Pharmaceutical and Medical Applications
1st Edition
Will be published approx. on 28. November 2025
Book
Paperback/Softback
314 pages
978-1-032-22867-9 (ISBN)
Description
The increasing availability and decreasing costs of 3D printing and bioprinting technologies are expanding opportunities to meet medical needs. 3D Printing and Bioprinting for Pharmaceutical and Medical Applications discusses emerging approaches related to these game-changer technologies in such areas as drug development, medical devices, and bioreactors.
Key Features:
Offers an overview of applications, the market, and regulatory analysis
Analyzes market research of 3D printing and bioprinting technologies
Reviews 3D printing of novel pharmaceutical dosage forms for personalized therapies and for medical devices, as well as the benefits of 3D printing for training purposes
Covers 3D bioprinting technology, including the design of polymers and decellularized matrices for bio-inks development, elaboration of 3D models for drug evaluation, and 3D bioprinting for musculoskeletal, cardiovascular, central nervous system, ocular, and skin applications
Provides risk-benefit analysis of each application
Highlights bioreactors, regulatory aspects, frontiers, and challenges
This book serves as an ideal reference for students, researchers, and professionals in materials science, bioengineering, the medical industry, and healthcare.
Key Features:
Offers an overview of applications, the market, and regulatory analysis
Analyzes market research of 3D printing and bioprinting technologies
Reviews 3D printing of novel pharmaceutical dosage forms for personalized therapies and for medical devices, as well as the benefits of 3D printing for training purposes
Covers 3D bioprinting technology, including the design of polymers and decellularized matrices for bio-inks development, elaboration of 3D models for drug evaluation, and 3D bioprinting for musculoskeletal, cardiovascular, central nervous system, ocular, and skin applications
Provides risk-benefit analysis of each application
Highlights bioreactors, regulatory aspects, frontiers, and challenges
This book serves as an ideal reference for students, researchers, and professionals in materials science, bioengineering, the medical industry, and healthcare.
More details
Series
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
Postgraduate and Professional Reference
Illustrations
58 s/w Photographien bzw. Rasterbilder, 15 s/w Zeichnungen, 73 s/w Abbildungen
15 Line drawings, black and white; 58 Halftones, black and white; 73 Illustrations, black and white
Dimensions
Height: 234 mm
Width: 156 mm
Thickness: 18 mm
Weight
509 gr
ISBN-13
978-1-032-22867-9 (9781032228679)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Jose Luis Pedraz Munoz | Laura Saenz del Burgo Martinez | Gustavo Puras Ochoa
3D Printing and Bioprinting for Pharmaceutical and Medical Applications
E-Book
09/2023
1st Edition
CRC Press
€69.99
Available for download
Jose Luis Pedraz Munoz | Laura Saenz del Burgo Martinez | Gustavo Puras Ochoa
3D Printing and Bioprinting for Pharmaceutical and Medical Applications
Book
09/2023
1st Edition
CRC Press
€173.30
Shipment within 10-20 days
Jose Luis Pedraz Munoz | Laura Saenz del Burgo Martinez | Gustavo Puras Ochoa
3D Printing and Bioprinting for Pharmaceutical and Medical Applications
E-Book
09/2023
1st Edition
CRC Press
€69.99
Available for download
Persons
Jose Luis Pedraz is Professor and principal researcher in the NanoBioCel group at the University of the Basque Country (UPV/EHU). The research group belongs to the CIBER-BBN of the Carlos III Health Institute, where he serves as the head and director of the medicine formulation laboratory (ICTS) Nanbiosis. Dr. Pedraz is also founder and director of the Pharmaceutical Development Unit of the Basque Country, currently TECNALIA Pharma Labs integrated in the TECNALIA Corporation within a joint project with the UPV/EHU, of which he is scientific director. He had a PhD in Pharmacy from the University of Salamanca.
Gustavo Puras is Professor at University of the Basque Country (UPV/EHU), Department of Pharmacy and Food Sciences. He is a member of the NanoBioCel research group at UPV/EHU and the National System of Researchers of Mexico (SNI). He is Professor in the Master's Program of Pharmacology, Development, Evaluation and Rational Use of Medicines at UPV/EHU. He received a PhD in Pharmacy from UPV/EHU.
Laura Saenz del Burgo is Professor at the University School of Nursing in Vitoria-Gasteiz and Associate Professor at University of the Basque Country (UPV/EHU) in the Department of Pharmacy and Food Sciences. She is a member of the NanoBioCel research group at UPV/EHU and part of the CIBER-BBN and gives technical assistance to the Nanbiosis platform (Drug Formulation). She received the PhD in Pharmacy from UPV/EHU and has worked as a postdoctoral researcher at the Institute of Molecular, Cell and Systems Biology, University of Glasgow.
Jon Zarate is Associate Professor, Department of Pharmacy and Food Sciences, Professor of the Doctoral Program in Drug Research and Evaluation, Application of Pharmaceutical Technology to the Development of Advanced Therapies, and Professor in the Master's Program in Pharmacology, Development, Evaluation and Rational Use of Medicines at University of the Basque Country (UPV/EHU). He is a member of the NanoBioCel research group at the same institution. He received a PhD in Pharmacy from UPV/EHU.
Gustavo Puras is Professor at University of the Basque Country (UPV/EHU), Department of Pharmacy and Food Sciences. He is a member of the NanoBioCel research group at UPV/EHU and the National System of Researchers of Mexico (SNI). He is Professor in the Master's Program of Pharmacology, Development, Evaluation and Rational Use of Medicines at UPV/EHU. He received a PhD in Pharmacy from UPV/EHU.
Laura Saenz del Burgo is Professor at the University School of Nursing in Vitoria-Gasteiz and Associate Professor at University of the Basque Country (UPV/EHU) in the Department of Pharmacy and Food Sciences. She is a member of the NanoBioCel research group at UPV/EHU and part of the CIBER-BBN and gives technical assistance to the Nanbiosis platform (Drug Formulation). She received the PhD in Pharmacy from UPV/EHU and has worked as a postdoctoral researcher at the Institute of Molecular, Cell and Systems Biology, University of Glasgow.
Jon Zarate is Associate Professor, Department of Pharmacy and Food Sciences, Professor of the Doctoral Program in Drug Research and Evaluation, Application of Pharmaceutical Technology to the Development of Advanced Therapies, and Professor in the Master's Program in Pharmacology, Development, Evaluation and Rational Use of Medicines at University of the Basque Country (UPV/EHU). He is a member of the NanoBioCel research group at the same institution. He received a PhD in Pharmacy from UPV/EHU.
Content
Chapter 1 3D Printing and Bioprinting Technologies in Pharmaceutics: Commercial Perspectives and Market Analytics
Suihong Liu, Yakui Liu, Qingxi Hu, Haiguang Zhang, Jeong-Hui Park, Khandmaa Dashnyam, Jung-Hwan Lee, Lijia Cheng, Zheng Shi, Barkan Kagan Durukan, Hilal Turkoglu Sasmazel, Serge Ostrovidov, Hirokazu Kaji, Rouhollah Mehdinavaz Aghdam, Alireza Jenabi, Mohammed Alqahtani, Mohamed Abbas, Jose Luis Pedraz Munoz, Seeram Ramakrishna, Hae-Won Kim, and Murugan Ramalingam
Chapter 2 3D Printing of New Drugs: Pharmaceutical Dosage Forms in Personalised Therapies
Alvaro Goyanes and Iria Seoane-Viano
Chapter 3 3D Printing for In Vitro Drug Release Analysis and Cell Culture Applications
Daniel Andres Real, Marcelo Javier Kogan, Santiago Daniel Palma, and Juan Pablo Real
Chapter 4 3D Printing of Medical Devices
Mary B. McGuckin, Achmad Himawan, Linlin Li, Jiaqi Gao, Qonita Kurnia Anjani, Yara Naser, Ke Peng, Camila J. Picco, Anna Korelidou, Rand Ghanma, and Eneko Larraneta
Chapter 5 Polymers for Bioinks Development
Patricia Diaz-Rodriguez and Luis Diaz-Gomez
Chapter 6 Decellularized Matrices for Bioink Development
Daniel P. Reis, Luca Gasperini, and Alexandra P. Marques
Chapter 7 3D Bioprinting for Musculoskeletal Applications
Sandra Ruiz-Alonso, Fatima Garcia-Villen, Ilia Villate-Beitia, Fouad Alhakim-Khalak, Jorge Ordoyo-Pascual, Lucia Enriquez-Rodriguez, Jon Zarate Sesma, Gustavo Puras Ochoa, Laura Saenz Del Burgo Martinez, and Jose Luis Pedraz Munoz
Chapter 8 3D Bioprinting for Cardiovascular Applications
N. Matthews, S. Ly, D. West, and C. Gentile
Chapter 9 3D Bioprinting for Central Nervous System Applications
Denis Scaini
Chapter 10 3D Bioprinting for Ocular Applications
Idoia Gallego, Markel Lafuente-Merchan, Myriam Sainz-Ramos, Ivan Maldonado, Jon Zarate Sesma, Laura Saenz del Burgo Martinez, Gustavo Puras Ochoa, Jose Luis Pedraz Munoz, and Hodei Gomez-Fernandez
Chapter 11 Bioreactors for Tendon Constructs
J. M. H. Spiering's and J. Foolen
Chapter 12 Bioprinted Combined Medicinal Products: Regulatory Challenges for Their Authorization and Commercialization
Eva Martin-Becerra, Rossana Garcia-Castro, and Ana Torres-Garcia
Chapter 13 3D-Bioprinted Scaffold Technology to Promote Articular Cartilage Regeneration in Osteoarthritis: An Example of Challenges of 3D Bioprinting
A. Mallick, V. Ward, M. B. O'Reilly, G. P. Duffy, and T. Mitra
Suihong Liu, Yakui Liu, Qingxi Hu, Haiguang Zhang, Jeong-Hui Park, Khandmaa Dashnyam, Jung-Hwan Lee, Lijia Cheng, Zheng Shi, Barkan Kagan Durukan, Hilal Turkoglu Sasmazel, Serge Ostrovidov, Hirokazu Kaji, Rouhollah Mehdinavaz Aghdam, Alireza Jenabi, Mohammed Alqahtani, Mohamed Abbas, Jose Luis Pedraz Munoz, Seeram Ramakrishna, Hae-Won Kim, and Murugan Ramalingam
Chapter 2 3D Printing of New Drugs: Pharmaceutical Dosage Forms in Personalised Therapies
Alvaro Goyanes and Iria Seoane-Viano
Chapter 3 3D Printing for In Vitro Drug Release Analysis and Cell Culture Applications
Daniel Andres Real, Marcelo Javier Kogan, Santiago Daniel Palma, and Juan Pablo Real
Chapter 4 3D Printing of Medical Devices
Mary B. McGuckin, Achmad Himawan, Linlin Li, Jiaqi Gao, Qonita Kurnia Anjani, Yara Naser, Ke Peng, Camila J. Picco, Anna Korelidou, Rand Ghanma, and Eneko Larraneta
Chapter 5 Polymers for Bioinks Development
Patricia Diaz-Rodriguez and Luis Diaz-Gomez
Chapter 6 Decellularized Matrices for Bioink Development
Daniel P. Reis, Luca Gasperini, and Alexandra P. Marques
Chapter 7 3D Bioprinting for Musculoskeletal Applications
Sandra Ruiz-Alonso, Fatima Garcia-Villen, Ilia Villate-Beitia, Fouad Alhakim-Khalak, Jorge Ordoyo-Pascual, Lucia Enriquez-Rodriguez, Jon Zarate Sesma, Gustavo Puras Ochoa, Laura Saenz Del Burgo Martinez, and Jose Luis Pedraz Munoz
Chapter 8 3D Bioprinting for Cardiovascular Applications
N. Matthews, S. Ly, D. West, and C. Gentile
Chapter 9 3D Bioprinting for Central Nervous System Applications
Denis Scaini
Chapter 10 3D Bioprinting for Ocular Applications
Idoia Gallego, Markel Lafuente-Merchan, Myriam Sainz-Ramos, Ivan Maldonado, Jon Zarate Sesma, Laura Saenz del Burgo Martinez, Gustavo Puras Ochoa, Jose Luis Pedraz Munoz, and Hodei Gomez-Fernandez
Chapter 11 Bioreactors for Tendon Constructs
J. M. H. Spiering's and J. Foolen
Chapter 12 Bioprinted Combined Medicinal Products: Regulatory Challenges for Their Authorization and Commercialization
Eva Martin-Becerra, Rossana Garcia-Castro, and Ana Torres-Garcia
Chapter 13 3D-Bioprinted Scaffold Technology to Promote Articular Cartilage Regeneration in Osteoarthritis: An Example of Challenges of 3D Bioprinting
A. Mallick, V. Ward, M. B. O'Reilly, G. P. Duffy, and T. Mitra